Zee NewsUrban Indians face greater heart disease riskZee NewsUrban India is moving to lifestyle diseases from infectious diseases due to a sedentary life, poor healthy food and lack of physical activity, Apollo Hospitals cardiologist Girish B Navasundi…
Artificial heart now in India, price Rs 1 croreEconomic TimesMUMBAI: A tiny mechanized device weighing 400 grams may give hope to more than 4 million people in the country who die of heart failure every year. A Mumbai hospital has brought in the techno…
When the Buccaneers hired Greg Schiano from Rutgers earlier this year, few league insiders had much to say.
Cuba launches first nanopharmaceuticalChannel News AsiaHAVANA: Cuba has unveiled its first manufactured nanopharmaceutical drug — a tweaked variety of cyclosporine, used to help prevent transplant rejection — official media reported Saturday. "I…
Of women, kids and CVDTimes of IndiaWHO estimates that India will lose 237 billion dollars in national income from premature deaths due to heart disease , stroke and diabetes by 2015. We all can make an effort to educate our family members and friends …
FRANCE 24Cuba launches first nanopharmaceuticalFRANCE 24Cuba has unveiled its first manufactured nanopharmaceutical drug — a tweaked variety of cyclosporine, used to help prevent transplant rejection — official media reported Saturday. AFP – Cuba has…
Cuba launches nanopharmaceutical drugThe AustralianCUBA has unveiled its first manufactured nanopharmaceutical drug – a tweaked variety of cyclosporine, used to help prevent transplant rejection – official media reported. "Its main advantages are …
Cuba launches nanopharmaceutical drugHerald SunCUBA has unveiled its first manufactured nanopharmaceutical drug – a tweaked variety of cyclosporine, used to help prevent transplant rejection – official media reported. "Its main advantages are that…
CUBA has unveiled its first manufactured nanopharmaceutical drug – a tweaked variety of cyclosporine, used to help prevent transplant rejection.
AFPCuba launches first nanopharmaceuticalAFPHAVANA — Cuba has unveiled its first manufactured nanopharmaceutical drug — a tweaked variety of cyclosporine, used to help prevent transplant rejection — official media reported Saturday. "Its main …